Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
Clinical trial NCT06488222 · RECRUITING
Trial details
- NCT number
- NCT06488222
- Sponsor
- University of Florida
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-05
- Primary completion
- 2027-08-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.